BA

Lipid Signaling Compounds

Lipids as Signaling Compounds

  • Lipids have multiple roles in the body:
    • Storage form as triglycerides.
    • Structural component of cell membranes (5-10% of cell mass).
    • Signaling compounds (active role).

Lipid Signaling Mechanisms

  • Signaling lipids can act as:
    • Potent hormones (steroid hormones like estrogen and testosterone).
    • Intracellular messengers (PIP2 signaling pathway).
    • Cofactors for enzymes.
  • Signaling can be extracellular or intracellular.

Extracellular Lipid Signals: Steroid Hormones

  • Steroid hormones:
    • Oxidized versions of cholesterol.
    • Travel through the blood to target tissues.
    • Enter cells via receptors with high affinity, requiring only tiny concentrations to elicit a response.
    • Bind to receptors in the nucleus, causing changes in gene expression.
  • Steroid drugs (e.g., prednisone) are anti-inflammatory.
    • They block phospholipase A2, preventing the release of arachidonic acid from membrane phospholipids.
    • This reduces the production of inflammatory compounds from arachidonic acid.
    • NSAIDs block phospholipase A2.

Intracellular Lipid Signals

  • Phosphatidylinositols (e.g., PIP2, PIP3).
  • Ceramides regulate cell division, differentiation, and apoptosis.
  • Ceramide production in muscles is associated with insulin resistance.
    • Immobilization of muscle increases ceramide concentration, leading to insulin resistance.
    • Exercise decreases ceramide concentration, improving insulin sensitivity.

Eicosanoids: Paracrine Signaling Molecules

  • Eicosanoids:
    • Paracrine signals (act on nearby cells).
    • Short half-life.
    • Derived from 20-carbon fatty acids (arachidonic acid and EPA).
    • Functions include inflammation, blood pressure regulation, and uterine muscle contraction.

Two Phases of Eicosanoid Production

  • Initial inflammatory phase:
    • Stimulated by infection, trauma, or viral triggers.
    • Produces prostaglandins (PG), thromboxanes (TX), and leukotrienes (LT).
  • Resolution phase (cleanup mechanism):
    • Resolves and cleans up excessive inflammation.
    • Produces resolvins, lipoxins, and protectins.

Naming Eicosanoids

  • Two-letter abbreviation indicates the type of eicosanoid (PG, TX, LT).
  • Third letter indicates where it was originally found or the order of discovery.
  • Subscript number (series number) indicates the number of double bonds.

Prostaglandins (PG)

  • First discovered in the prostate gland.
  • Involved in various functions:
    • Uterine contractions (delivery).
    • Menstruation.
    • Sleep-wake cycle regulation.
    • Fever (prostaglandins can induce fever).

Thromboxanes (TX)

  • Produced by platelets (thrombocytes).
  • Mainly involved in clotting:
    • Stimulate platelet aggregation; they make platelets sticky.
    • Restrict blood flow to the clot site.
  • NSAIDs (ibuprofen, aspirin) inhibit thromboxane synthesis, thinning the blood.

Leukotrienes (LT)

  • Produced by white blood cells (leukocytes).
  • Potent signaling compounds:
    • Cause anaphylactic shock and allergic reactions.
    • Stimulate asthmatic reactions.
    • Induce generalized inflammation (the worst inflammation offenders).

Eicosanoid Synthesis Pathways

  • Requires release of arachidonic acid and EPA from membrane phospholipids via phospholipase A2 activation.
  • Two main pathways:
    • Cyclooxygenase (COX) pathway (cyclic pathway).
    • Lipoxygenase (LOX) pathway (linear pathway).

Cyclooxygenase (COX) Pathway

  • Also known as the cyclic pathway because it puts a ring in the structure.
  • Removes two double bonds during the process.
  • Highly dependent on the starting fatty acid.

Lipoxygenase (LOX) Pathway

  • Also known as the linear pathway because it does not put a ring into the structure.
  • Does not change the number of double bonds.
  • Rearranges the structure, but the total number of double bonds remains the same.

Eicosanoid Synthesis from Arachidonic Acid (ARA)

  • Arachidonic acid (ARA): 20 carbons, 4 double bonds (omega-6).
  • COX pathway:
    • Removes two double bonds (4 - 2 = 2).
    • Produces two-series prostaglandins (e.g., PGE2).
    • Two-series prostaglandins are converted to two-series thromboxanes (e.g., TXA2).
  • LOX pathway:
    • Does not change the number of double bonds.
    • Produces four-series leukotrienes (e.g., LTB4).

Eicosanoid Synthesis from Eicosapentaenoic Acid (EPA)

  • EPA: 20 carbons, 5 double bonds (omega-3).
  • COX pathway:
    • Removes two double bonds (5 - 2 = 3).
    • Produces three-series prostaglandins (e.g., PGE3).
    • Three-series prostaglandins are converted to three-series thromboxanes (e.g., TXA3).
  • LOX pathway:
    • Does not change the number of double bonds.
    • Produces five-series leukotrienes (e.g., LTB5).

Bioactivity of Eicosanoids

  • Eicosanoids derived from arachidonic acid are more bioactive (more potent).
  • Eicosanoids derived from EPA are weaker (three-series prostaglandins/thromboxanes and five-series leukotrienes).

Functions of Eicosanoids

  • Vasodilation and Vascular Tone
  • Uterine contractions
  • Labor Induction
  • Gastric mucus production
  • Smooth muscle contraction
  • Vascular adhesion

Enzyme Specificity and Eicosanoid Production

  • Cells selectively activate enzymes to produce specific eicosanoids.
  • Quantities produced are altered by the physiologic conditions of the cell.
  • Eicosanoids do not travel far; they are paracrine signals, not hormones.
  • The COX enzyme has a lower K_m for arachidonic acid (prefers arachidonic acid).
  • The LOX enzyme prefers EPA (lower K_m for EPA).

COX and LOX Isoforms

  • COX1, COX2, and COX3 (in the brain) isoforms involved in gastric secretions, pain, and fever.
  • Different isoforms make different types of prostaglandins and thromboxanes.
  • Generalized NSAIDs (ibuprofen) bind both COX1 and COX2, decreasing the mucosal barrier in the stomach and leading to gastric irritation.

Inflammatory Lipids and Proteins

  • Leukotrienes are highly inflammatory.
  • Inflammatory proteins:
    • Histamine (from histidine).
    • Cytokines (acute phase proteins like interleukin-6, tumor necrosis factor alpha, and interferons).
  • Chronic inflammation contributes to approximately 20% of all cancers.

EPA and Anti-Inflammatory Effects

  • Eicosanoids made from EPA are weak and less stimulatory than the ones made by arachidonic acid.
  • More EPA leads to less production of two-series prostaglandins and thromboxanes.
  • More EPA leads to more production of five-series leukotrienes and less of the inflammatory four-series leukotrienes.
  • Anti-inflammatory action from fish and fish oils is due to what WE ARE making LESS of AND what the body produces from EPA.

Specialized Pro-resolving Mediators (SPMs)

  • SPMs: resolvins, protectins, and lipoxins (anti-inflammatory compounds).
  • Made primarily from EPA and DHA (omega-3s).

Anti-Inflammatory Effects of Exercise

  • Exercise increases inflammatory compounds like interleukin-6, but also increases anti-inflammatory interleukin-10.
  • Overall, chronic exercise leads to a greater anti-inflammatory response.

Fish Consumption and Omega-3 Intake

  • Limit consumption of shark, swordfish, tilefish, and king mackerel (high in mercury, from the Gulf of Mexico).
  • Pregnant women should eat fish (8-12 ounces of low-mercury fish per week): about two to three servings overall.
  • Salmon, catfish, and tuna are good choices.
  • Avoid tilefish from the Gulf of Mexico, shark, swordfish, and king mackerel during pregnancy.
  • Limit albacore tuna to 6 ounces per week during pregnancy (higher in mercury).
  • Methylmercury in fish is neurotoxic, but protective mechanisms (glutathione, antioxidants) help decrease oxidative stress.